ECG
ELV icon

Edge Capital Group’s Elevance Health ELV Stock Holding History

Edge Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-509
Closed -$276K – 329
2024
Q2 		$276K Hold
509
– – 0.01% 271
2024
Q1 		$264K Sell
509
-45
-8% -$22.4K 0.01% 275
2023
Q4 		$261K Buy
554
+11
+2% +$5.09K 0.01% 268
2023
Q3 		$236K Hold
543
– – 0.02% 261
2023
Q2 		$241K Buy
543
+467
+614% +$215K 0.01% 279
2023
Q1 		$34.9K Hold
76
– – ﹤0.01% 367
2022
Q4 		$39K Buy
76
+30
+65% +$15.2K ﹤0.01% 354
2022
Q3 		$21K Sell
46
-5,719
-99% -$2.74M ﹤0.01% 334
2022
Q2 		$355K Buy
+5,765
New +$2.85M 0.03% 217

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edge Capital Group's ELV Position: Q3 2024 in Review

Edge Capital Group sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 509 shares — an estimated $276K sold.

Edge Capital Group first reported a position in ELV in Q2 2022 and held it in 9 quarters. The position peaked at $355K in Q2 2022. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Edge Capital Group reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Edge Capital Group sold 509 Elevance Health shares in Q3 2024, an estimated $276K.
  • Edge Capital Group first reported a position in Elevance Health in Q2 2022 and held it in 9 quarters.
  • Edge Capital Group's Elevance Health position peaked at $355K in Q2 2022.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Edge Capital Group's 13F filing for Q3 2024, filed 12 Nov 2024.